Search

everythinglearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

miR-22 helps skin cancer grow and spread by activating specific cell signals.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

A pathway helps maintain long telomeres in both stem and cancer cells.

CXCR2 in skin cells promotes tumor growth.

Disrupting β-catenin signaling in certain cells causes anorectal malformations.

Genetic discoveries are leading to new treatments for alopecia areata.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

BST2 is a key marker for hair loss disease alopecia areata.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Screening for the NUDT15 gene variant can prevent severe side effects from thiopurine drugs in East-Asian people.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

A new genetic mutation in the CDH3 gene causes hair loss and eye problems in young people.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Björnstad syndrome can cause hair loss similar to androgenetic alopecia, and treatment with baricitinib and minoxidil may help.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Recognizing congenital triangular alopecia is crucial to avoid unnecessary treatments.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

Researchers found a new mutation causing total hair loss from birth.